Highly active anti-retroviral therapy (HAART) is the standard of care for HIV infection; however, pharmacogenomic approaches highlighted significant interindividual differences in drug disposition, ...
A new study, led by Prof. Liu from the department of pharmacy, University of Electronic Science and Technology of China, discovered that the extracellular cell matrix (ECM) could induce the drug ...
Delsitech Ltd. and Tolmar International Ltd. have signed a global license and development agreement whereby Tolmar will obtain a global license to utilize Delsitech’s proprietary, silica-based, drug ...